{
    "paper_id": "e7fac35fb2236ea3c42baca5f1b4e601d84902ec",
    "metadata": {
        "title": "A",
        "authors": []
    },
    "abstract": [],
    "body_text": [
        {
            "text": "registry-gateway to world, 265-268 source and quality of information, 286-287 stem cell trans-differentiation, [285] [286] [203] [204] [285] [286] [197] [198] 292, 301 banking setting, 198 CB plasma, [301] [302] [200] [201] [205] [206] 302 units, 204 in USA, 254 Arizona , 27, 9, 39, 630, 77, 113-114, 141, 156, 197, 249-250, 292 101, 113-114, 126, 167-168, 197-198, 249, 285, 291-292, 301, 314 ",
            "cite_spans": [
                {
                    "start": 111,
                    "end": 116,
                    "text": "[285]",
                    "ref_id": null
                },
                {
                    "start": 117,
                    "end": 122,
                    "text": "[286]",
                    "ref_id": null
                },
                {
                    "start": 123,
                    "end": 128,
                    "text": "[203]",
                    "ref_id": null
                },
                {
                    "start": 129,
                    "end": 134,
                    "text": "[204]",
                    "ref_id": null
                },
                {
                    "start": 135,
                    "end": 140,
                    "text": "[285]",
                    "ref_id": null
                },
                {
                    "start": 141,
                    "end": 146,
                    "text": "[286]",
                    "ref_id": null
                },
                {
                    "start": 147,
                    "end": 152,
                    "text": "[197]",
                    "ref_id": null
                },
                {
                    "start": 153,
                    "end": 158,
                    "text": "[198]",
                    "ref_id": null
                },
                {
                    "start": 159,
                    "end": 163,
                    "text": "292,",
                    "ref_id": null
                },
                {
                    "start": 164,
                    "end": 184,
                    "text": "301 banking setting,",
                    "ref_id": null
                },
                {
                    "start": 185,
                    "end": 199,
                    "text": "198 CB plasma,",
                    "ref_id": null
                },
                {
                    "start": 200,
                    "end": 205,
                    "text": "[301]",
                    "ref_id": null
                },
                {
                    "start": 206,
                    "end": 211,
                    "text": "[302]",
                    "ref_id": null
                },
                {
                    "start": 212,
                    "end": 217,
                    "text": "[200]",
                    "ref_id": null
                },
                {
                    "start": 218,
                    "end": 223,
                    "text": "[201]",
                    "ref_id": null
                },
                {
                    "start": 224,
                    "end": 229,
                    "text": "[205]",
                    "ref_id": null
                },
                {
                    "start": 230,
                    "end": 235,
                    "text": "[206]",
                    "ref_id": null
                },
                {
                    "start": 236,
                    "end": 246,
                    "text": "302 units,",
                    "ref_id": null
                },
                {
                    "start": 247,
                    "end": 258,
                    "text": "204 in USA,",
                    "ref_id": null
                },
                {
                    "start": 259,
                    "end": 262,
                    "text": "254",
                    "ref_id": null
                },
                {
                    "start": 273,
                    "end": 329,
                    "text": "27, 9, 39, 630, 77, 113-114, 141, 156, 197, 249-250, 292",
                    "ref_id": null
                },
                {
                    "start": 330,
                    "end": 394,
                    "text": "101, 113-114, 126, 167-168, 197-198, 249, 285, 291-292, 301, 314",
                    "ref_id": null
                }
            ],
            "ref_spans": [],
            "section": ""
        }
    ],
    "bib_entries": {
        "BIBREF1": {
            "ref_id": "b1",
            "title": "Somatic cell nuclear transfer SD. See Standard deviation SDF-1. See Stromal cell-derived factor 1 Secondary progressive-Multiple Sclerosis",
            "authors": [
                {
                    "first": "",
                    "middle": [],
                    "last": "Scnt",
                    "suffix": ""
                },
                {
                    "first": "",
                    "middle": [],
                    "last": "See",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF2": {
            "ref_id": "b2",
            "title": "Serious adverse reactions",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF3": {
            "ref_id": "b3",
            "title": "Serological typing",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "64--65",
            "other_ids": {}
        },
        "BIBREF4": {
            "ref_id": "b4",
            "title": "Severe acquired aplastic anemia (SAA)",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF5": {
            "ref_id": "b5",
            "title": "Severe Acute Respiratory Syndrome (SARS)",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF7": {
            "ref_id": "b7",
            "title": "Sex-determining region Y (SRY)",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF8": {
            "ref_id": "b8",
            "title": "See French Society for blood and marrow Transplantation and cellular therapy Shewhart Cycle. See Plan-Do-Check-Act cycle (PDCA cycle) Sickle cell disease (SCD)",
            "authors": [
                {
                    "first": "",
                    "middle": [],
                    "last": "Sfgm-Tc",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF9": {
            "ref_id": "b9",
            "title": "See small interfering RNAs \"Six Sigma\" approach",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF10": {
            "ref_id": "b10",
            "title": "Systemic lupus erythematosus small interfering RNAs (siRNA)",
            "authors": [
                {
                    "first": "",
                    "middle": [],
                    "last": "Sle",
                    "suffix": ""
                },
                {
                    "first": "",
                    "middle": [],
                    "last": "See",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "157--158",
            "other_ids": {}
        },
        "BIBREF11": {
            "ref_id": "b11",
            "title": "Solid organ transplantation",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "132",
            "issn": "",
            "pages": "128--129",
            "other_ids": {}
        },
        "BIBREF12": {
            "ref_id": "b12",
            "title": "See Standard operating procedure SP-MS. See Secondary progressive-Multiple Sclerosis SRY. See Sex-determining region Y SSc. See Scleroderma SSEA. See Stage-specific embryonic antigen Stage-specific embryonic antigen",
            "authors": [],
            "year": null,
            "venue": "180f SOP",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF13": {
            "ref_id": "b13",
            "title": "See also Quality Umbilical cord mesenchymal stromal cells (UC MSC",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "118",
            "issn": "",
            "pages": "132--133",
            "other_ids": {}
        },
        "BIBREF14": {
            "ref_id": "b14",
            "title": "Unconventional lymphoid T cells",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF15": {
            "ref_id": "b15",
            "title": "Unrelated cord blood transplantation (UCBT)",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF16": {
            "ref_id": "b16",
            "title": "Unrelated donor bone marrow transplantation (UDBMT)",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "63--64",
            "other_ids": {}
        },
        "BIBREF17": {
            "ref_id": "b17",
            "title": "Unrestricted somatic stem cell (USSC)",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "10",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF19": {
            "ref_id": "b19",
            "title": "US Food and Drug Administration (FDA)",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "188",
            "issn": "",
            "pages": "246--247",
            "other_ids": {}
        },
        "BIBREF20": {
            "ref_id": "b20",
            "title": "Unrestricted somatic stem cell V Vascular endothelial growth factor (VEGF)",
            "authors": [
                {
                    "first": "",
                    "middle": [],
                    "last": "Ussc",
                    "suffix": ""
                },
                {
                    "first": "",
                    "middle": [],
                    "last": "See",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF22": {
            "ref_id": "b22",
            "title": "Very small embryonic-like cells (VSEL cells",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF23": {
            "ref_id": "b23",
            "title": "Virgin Health Bank model (VHB model), 327 \"Virtual\" phenotypes",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "216--217",
            "other_ids": {}
        },
        "BIBREF24": {
            "ref_id": "b24",
            "title": "Visceral adipose tissue",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF26": {
            "ref_id": "b26",
            "title": "White blood cells (WBCs)",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "27--28",
            "other_ids": {}
        },
        "BIBREF31": {
            "ref_id": "b31",
            "title": "Worldwide Network for Blood and Marrow Transplantation (WBMT)",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        }
    },
    "ref_entries": {
        "TABREF0": {
            "text": "See Bone marrow BMDW. See Bone Marrow Donor Worldwide BMMSC. See Bone marrow mesenchymal stromal cells BMP. See Bone morphogenetic protein BMT. See Bone marrow transplantation BMT-CTN. See Blood and Marrow Transplant Clinical Trials Network See Chronic lymphoid leukemia Clonal populations, 12 CM. See Cardiac myosin CMV. See Cytomegalovirus CNIs. See Calcineurin inhibitors CNS. See Central nervous system CNVs. See Copy number variations COBLT. See Cord Blood Transplantation",
            "latex": null,
            "type": "table"
        },
        "TABREF2": {
            "text": "See Dendritic cells DCBT. See Double cord blood transplantation DDP4. See Dipeptidyl peptidase 4 Deming Cycle. See Plan-Do-Check-Act cycle See European Parliament EPCs. See Endothelial progenitor cells Epidermal growth factor (EGF), 20-21 Epstein Barr virus (EBV), 41, 147-148 Equipment validation. See Performance verification ER. See Endoplasmic reticulum eSAR. See Electronic administration system ESC-EC. See Embryonic stem cells-endothelial cells Ethnic minorities (EM), 199 EU. See European Union EULAR. See European League against Event-free survival (EFS), 143 Experimental acute encephalomyelitis (EAE), 114-115, 118 FACS. See Fluorescence-activated cell sorting FACT. See Foundation for the Accreditation of Cellular Therapy FACT-NetCord, 197-198, 205 FBP1. See Fructose 1,6-bisphosphatase FBS. See Fetal bovine serum FCS. See Fetal calf serum FDA. See US Food and Drug Administration Federal Drug Administration. See US Food and Drug Administration (FDA) Fetal bovine serum (FBS), 301 Fetal calf serum (FCS), 17, 301 HALE. See Health-adjusted life expectancy Haplotype, 64 HCT/Ps. See Human cells, tissues, and cellular and tissue-based products Health indicators, new trends in, 354-355",
            "latex": null,
            "type": "table"
        },
        "TABREF3": {
            "text": "See human embryonic stem cells HGF. See Hepatocyte growth factor HH proteins. See Hedgehog proteins HHS. See US Department of Health and Human Services HIE. See Hypoxic-ischemic encephalopathy See Human induced pluripotent stem cells HLA. See Human leukocyte antigen HLA-G. See Human leukocyte antigen G HNF4\u03b1. See Hepatocyte nuclear factor 4 \u03b1 Homeobox (HOX), 10-11 Host-versus-Graft direction (HvG direction), 91 HPC. See Hematopoietic progenitor cells HPP-CFCs. See High proliferative potential colony-forming cells HPP-ECFC. See High proliferative potential endothelial colony-forming cells HSC. See Hematopoietic stem cells HSCT. See Hematopoietic stem cell transplantation HSPC. See Hematopoietic stem/progenitor cells HUCACs. See Human umbilical cord arteryderived endothelial cells HUCB-MSC. See Human umbilical cord blood-IBMTR. See International Blood and Marrow Transplantation Registry ICRS. See International Cartilage Repair Society ICT. See Information and communication technologies IDM. See Infectious disease markers IDO. See Indoleamine-2,3-dioxygenase IL-2. See Interleukin-2 IMA. See Inherited Maternal Antigens IMD. See Inherited metabolic disease See Institute of Medicine IPA. See Inherited paternal antigens IPCs. See Insulin-producing cells IPS. See Induced reprogramming of somatic cells iPS-derived endothelial cells (iPS-ECs), See International Society for Cellular Therapy Islet \u03b2 cells regeneration, 158-159 ISO. See International Organization for Standardization IVH. See Intraventricular hemorrhage IVT. See In vitro transcription templates QA. See Quality assurance QC. See Quality control QHOM. See Quality Health Outcomes Model QI. See Quality improvement QM. See Quality management QMP. See Quality management plan QMPr. See Quality management principles QMS. See Quality management system QMU. See Quality management unit QS. See Quality supervisor Stromal cell-derived factor 1 (SDF-1), 19, 22, 95 Stromal cells. See Stem cells Structure-process-outcomes model, 246 Systemic lupus erythematosus (SLE), 115-116, 118-120, 133 See Transforming growth factor-\u03b2 TGO 88. See Therapeutic Goods Order No. 88 Thalassemia major (TM), 80 Therapeutic angiogenesis, 293 Therapeutic Goods Order No. 88 (TGO 88), 258 Third-party agreements, 238 THPO. See Thrombopoietin Thrombopoietin (THPO), 17 Thrombopoietin (TPO), 94 Thymic-dependent pathway, 41-42 Thymic-independent pathway, 41 Tissue differentiation from iPSC functional test, 186 hiPSCs differentiation, 184-185 phenotyping, 186 Tissue economies, 341 biological capitalization, 342 community vs. commodity, 341 guaranteeing storage, not graft, 342 impasses and dilemmas, 342-343 \"public good and privatization of self\", 341 self-sufficiency and dependency, 342 Tissue Engineering and Regenerative Medicine International Society (TERMIS), 298 Tissue repair, 285-286 TM. See Thalassemia major TNC. See Total nucleated cells TNF\u03b1. See Tumor necrosis factor-\u03b1 Total body irradiation (TBI), 145 Total nucleated cells (TNC), 66, 79, 141-142, 198, 212, 264-265, 335 Total quality management (TQM), 230, 236-237 TPO. See Thrombopoietin TQM. See Total quality management Traceability, 362 Transforming growth factor-\u03b2 (TGF\u03b2), 185 Transfusion. See Transplantation Transplant-related mortality (TRM), 66, 81, 115-116, 142, 212 Transplantation, 187-188 Treg cell therapy in, 128-129 TREC. See T-cell receptor excision circle Treg-specific demethylation region (TSDR), 126 Tregs. See Regulatory T cells TRM. See Transplant-related mortality TSDR. See Treg-specific demethylation region Tumor necrosis factor-\u03b1 (TNF\u03b1), 154 Type 1 diabetes (T1D), 118-119, 127-128, 153-154. See also Stem cell educator therapy Type 2 diabetes (T2D), 153-154. See also Stem cell educator therapy insulin resistance, 154 metabolic abnormalities, 154-155 metabolic inflammation pathophysiology, 154 UC. See Umbilical cord UC MSC. See Umbilical cord mesenchymal stromal cells UCB. See Umbilical cord blood UCB-derived MSC EAE, cord blood and, 118 genetically prone diabetes, cord blood and, 118-119 genetically prone lupus, cord blood and, 118 MS, 119 pSS, 120 RA, cord blood and, 118 SLE, 119-120 UCBT. See Unrelated cord blood transplantation UDBMT. See Unrelated donor bone marrow transplantation UK Royal College of Obstetricians and Gynaecologists (RCOG), 201 Umbilical CB transplantation, 78 Umbilical cord (UC), 292 arteries, 302 Umbilical cord, 125 MSC, 130-133 Treg, 125-130 Umbilical cord blood (UCB),",
            "latex": null,
            "type": "table"
        },
        "TABREF4": {
            "text": ". See also Cord blood bank (CBB) banking setting, 198 CB plasma, 301-302 cellular product in regenerative medicine, 57 collection, 200 in utero vs. ex utero collections, 200-201 communication of information, 318-319 diabetic environment effects, 54-55 donation, 319 on gestational age, 53-54 obstetric factors and ECFC content, 52-53 operational aspects, 199f processing and cryopreservation affect ECFC numbers in, 55 public UCB banking, 198 regenerative medicine and mesenchymal cells, 321-322 status of, 315-316 UC arteries, 302",
            "latex": null,
            "type": "table"
        }
    },
    "back_matter": []
}